Lenzilumab (Anti-CSF2 / GM-CSF)
Lenzilumab (Anti-CSF2 / GM-CSF) is a recombinant monoclonal antibody against the cytokine granulocyte macrophage colony-stimulating factor (GM-CSF), with potential immunomodulating activity. MW: 145.72 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2854 |
| Sku # | A2854-1mg*5 |
| Pricing | 1mg*5, $970.00 |